Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×

watch

MediciNova, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States


Exchange/Ticker: Nasdaq: MNOV | JASDAQ: 4875


Company Description

MediciNova, Inc. is a development stage company with interest in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need with a specific focus on the U.S. market. The company's development pipeline consists of eight product development programs which have been in clinical development for the treatment of asthma, acute exacerbations of asthma, diabetic neuropathic pain, opioid addiction, multiple sclerosis, other CNS disorders, interstitial cystitis, or IC, solid tumor cancers, Generalized Anxiety Disorder/insomnia, preterm labor and urinary incontinence. MediciNova was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in San Diego, CA.

Similar to: Columbia Laboratories, Inc., Sanofi, GW Pharmaceuticals Plc

Featured Company


Fidelity Asian Values Plc

Tadworth, SU, GB

Fidelity Asian Values Plc is a Closed-End Investment Fund/Investment. The company invests in information technology, energy, financial… Learn more →

You may also be interested in:


GW Pharmaceuticals Plc

Salisbury, WI, GB

GW Pharmaceuticals Plc researches and develops cannabinoid medicines. The companys principal activity is developing and manufacturing… Learn more →

Sanofi

Paris, FR

Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’… Learn more →

Columbia Laboratories, Inc.

Livingston, NJ, US

Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →